BrightPath Biotherapeutics Co (TSE:4594) Beta: -0.2644 (As of Jul. 11, 2026)

BrightPath Biotherapeutics Co  (TSE:4594) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

BrightPath Biotherapeutics Co Beta Related Terms

The historical data trend for BrightPath Biotherapeutics Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrightPath Biotherapeutics Co Beta Chart

BrightPath Biotherapeutics Co Annual Data
	Trend	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25	Mar26
Beta		Get a 7-Day Free Trial					0.90	1.13	0.78	0.39	-0.06

BrightPath Biotherapeutics Co Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25	Mar26
Beta	Get a 7-Day Free Trial															0.78	0.70	0.39	0.30	-0.06

TSE:4594 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, BrightPath Biotherapeutics Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BrightPath Biotherapeutics Co Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BrightPath Biotherapeutics Co's Beta distribution charts can be found below:

* The bar in red indicates where BrightPath Biotherapeutics Co's Beta falls into.

BrightPath Biotherapeutics Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

BrightPath Biotherapeutics Co Business Description